全球自動噴油嘴市場（2026-2030 年）

全球自動注射器市場預計在 2025 年至 2030 年間成長至 4,035.41 億美元，預測期內複合年成長率為 32.1%。

本報告對全球自動注射器市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括：全球慢性病盛行率的激增（需要長期自我給藥）、生物製藥和生物相似藥市場的快速擴張（需要專業的藥物輸送技術）以及智慧連接功能的整合（可即時提高患者的用藥依從性）。

本報告基於客觀的綜合分析，結合一手和二手資料，包括主要產業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模資料、細分市場數據及區域分析，以及供應商格局。此外，報告還包含歷史數據和預測數據。

本報告指出，與傳統注射器相比，透過體外給藥系統 (OBDS) 進行大容量給藥的商業性需求日益成長，這將是未來幾年全球自動注射器市場成長的主要驅動力之一。此外，永續和環保材料的策略性應用以及循環產品架構的構建，以及生物製藥公司與給藥技術專家之間不斷擴大的跨行業策略合作，預計也將產生巨大的市場需求。

目錄

第1章：執行摘要

第2章：Technavio 的分析

• 分析價格敏感度、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 混淆因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模評估

• 市場的定義
• 市場區隔分析
• 市場規模（2025 年）
• 市場展望（2025-2030 年）

第5章：實際市場規模

• 全球自動注射器市場（2020-2024）
• 按應用領域分析（2020-2024 年）
• 按最終用戶分類的分析（2020-2024 年）
• 按產品類型分類的分析（2020-2024 年）
• 區域分析（2020-2024）
• 各國分析（2020-2024 年）

第6章 定性分析

• 人工智慧的影響：全球自注射器市場
• 地緣政治衝突的影響：全球自動注射器市場

第7章：五力分析

第8章 市場區隔：依應用領域

• 比較：按應用
• 過敏反應
• 多發性硬化症
• 類風濕性關節炎
• 糖尿病
• 市場機會：依應用領域分類

第9章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 醫院和診所
• 自我管理
• 市場機會：依最終用戶分類

第10章 市場區隔：依產品類型

• 比較：依產品類型
• 一次性自注射器
• 可重複使用的自動注射器
• 市場機會：依產品類型分類

第11章 客戶情況

第12章 區域情勢

• 區域分類
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 印尼
  • 泰國
• 其他地區（ROW）
  • 巴西
  • 沙烏地阿拉伯
  • UAE
  • 土耳其
  • 南非
  • 阿根廷
  • 哥倫比亞
  • 以色列
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• AptarGroup Inc.
• Becton Dickinson and Co.
• Bespak Europe Ltd.
• Catalent Inc.
• Flex Ltd.
• Gerresheimer AG
• Halozyme Therapeutics Inc.
• Haselmeier GmbH
• Jabil Inc.
• Nipro Corp.
• Nolato AB
• Stevanato Group SpA
• Terumo Pharmaceutical Solutions
• West Pharma Services Inc.
• Ypsomed Holding AG

第16章附錄

The global autoinjectors market is forecasted to grow by USD 403504.1 mn during 2025-2030, accelerating at a CAGR of 32.1% during the forecast period. The report on the global autoinjectors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by surging global prevalence of chronic diseases demanding long term self administration capabilities, accelerated expansion of biologics and biosimilars market mandating specialized drug delivery, technological integration of smart connectivity features elevating real time patient compliance.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global autoinjectors market is segmented as below:

By Application

• Anaphylaxis
• Multiple sclerosis
• Rheumatoid arthritis
• Diabetes

By End-User

• Hospitals and clinics
• Self-administration

By Product Type

• Disposable autoinjectors
• Reusable autoinjectors

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the rising commercial preference for high volume on body delivery systems over traditional injectors as one of the prime reasons driving the global autoinjectors market growth during the next few years. Also, strategic adoption of sustainable eco friendly materials and circular product architectures and expansion of strategic cross sector partnerships between biopharma and delivery specialists will lead to sizable demand in the market.

The report on the global autoinjectors market covers the following areas:

• Global autoinjectors market sizing
• Global autoinjectors market forecast
• Global autoinjectors market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global autoinjectors market vendors that include AptarGroup Inc., Becton Dickinson and Co., Bespak Europe Ltd., Catalent Inc., Duoject Medical Systems Inc., Elcam Medical Group, Flex Ltd., Gerresheimer AG, Halozyme Therapeutics Inc., Haselmeier GmbH, Jabil Inc., Kindeva Drug Delivery L.P., MGS Manufacturing Group Inc., Nemera Group, Nipro Corp., Nolato AB, Stevanato Group S.p.A, Terumo Pharmaceutical Solutions, West Pharma Services Inc., Ypsomed Holding AG. Also, the global autoinjectors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Autoinjectors Market 2020 - 2024
  • Historic Market Size - Data Table on Global Autoinjectors Market 2020 - 2024 ($ million)
• 5.2 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Product Type segment analysis 2020 - 2024
  • Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global autoinjectors market
• 6.2 Impact of geopolitical conflicts on global autoinjectors market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Application

• 8.1 Market segments
• 8.2 Comparison by Application
• 8.3 Anaphylaxis - Market size and forecast 2025-2030
• 8.4 Multiple sclerosis - Market size and forecast 2025-2030
• 8.5 Rheumatoid arthritis - Market size and forecast 2025-2030
• 8.6 Diabetes - Market size and forecast 2025-2030
• 8.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals and clinics - Market size and forecast 2025-2030
• 9.4 Self-administration - Market size and forecast 2025-2030
• 9.5 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Product Type

• 10.1 Market segments
• 10.2 Comparison by Product Type
• 10.3 Disposable autoinjectors - Market size and forecast 2025-2030
• 10.4 Reusable autoinjectors - Market size and forecast 2025-2030
• 10.5 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 South Africa - Market size and forecast 2025-2030
  • 12.6.6 Argentina - Market size and forecast 2025-2030
  • 12.6.7 Colombia - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Surging global prevalence of chronic diseases demanding long term self administration capabilities
  • Accelerated expansion of biologics and biosimilars market mandating specialized drug delivery
  • Technological integration of smart connectivity features elevating real time patient compliance
• 13.2 Market challenges
  • Navigating complex technical hurdles in delivering high viscosity biopharmaceutical formulations
  • Overcoming environmental sustainability constraints associated with disposable plastic injection systems
  • Managing stringent combination product regulatory guidance and complex bioequivalence demonstrations
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Rising commercial preference for high volume on body delivery systems over traditional injectors
  • Strategic adoption of sustainable eco friendly materials and circular product architectures
  • Expansion of strategic cross sector partnerships between biopharma and delivery specialists

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 AptarGroup Inc.
  • AptarGroup Inc. - Overview
  • AptarGroup Inc. - Business segments
  • AptarGroup Inc. - Key news
  • AptarGroup Inc. - Key offerings
  • AptarGroup Inc. - Segment focus
  • SWOT
• 15.5 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.6 Bespak Europe Ltd.
  • Bespak Europe Ltd. - Overview
  • Bespak Europe Ltd. - Product / Service
  • Bespak Europe Ltd. - Key offerings
  • SWOT
• 15.7 Catalent Inc.
  • Catalent Inc. - Overview
  • Catalent Inc. - Product / Service
  • Catalent Inc. - Key offerings
  • SWOT
• 15.8 Flex Ltd.
  • Flex Ltd. - Overview
  • Flex Ltd. - Business segments
  • Flex Ltd. - Key offerings
  • Flex Ltd. - Segment focus
  • SWOT
• 15.9 Gerresheimer AG
  • Gerresheimer AG - Overview
  • Gerresheimer AG - Business segments
  • Gerresheimer AG - Key offerings
  • Gerresheimer AG - Segment focus
  • SWOT
• 15.10 Halozyme Therapeutics Inc.
  • Halozyme Therapeutics Inc. - Overview
  • Halozyme Therapeutics Inc. - Product / Service
  • Halozyme Therapeutics Inc. - Key offerings
  • SWOT
• 15.11 Haselmeier GmbH
  • Haselmeier GmbH - Overview
  • Haselmeier GmbH - Product / Service
  • Haselmeier GmbH - Key offerings
  • SWOT
• 15.12 Jabil Inc.
  • Jabil Inc. - Overview
  • Jabil Inc. - Business segments
  • Jabil Inc. - Key offerings
  • Jabil Inc. - Segment focus
  • SWOT
• 15.13 Nipro Corp.
  • Nipro Corp. - Overview
  • Nipro Corp. - Business segments
  • Nipro Corp. - Key offerings
  • Nipro Corp. - Segment focus
  • SWOT
• 15.14 Nolato AB
  • Nolato AB - Overview
  • Nolato AB - Business segments
  • Nolato AB - Key offerings
  • Nolato AB - Segment focus
  • SWOT
• 15.15 Stevanato Group S.p.A
  • Stevanato Group S.p.A - Overview
  • Stevanato Group S.p.A - Product / Service
  • Stevanato Group S.p.A - Key offerings
  • SWOT
• 15.16 Terumo Pharmaceutical Solutions
  • Terumo Pharmaceutical Solutions - Overview
  • Terumo Pharmaceutical Solutions - Product / Service
  • Terumo Pharmaceutical Solutions - Key offerings
  • SWOT
• 15.17 West Pharma Services Inc.
  • West Pharma Services Inc. - Overview
  • West Pharma Services Inc. - Business segments
  • West Pharma Services Inc. - Key offerings
  • West Pharma Services Inc. - Segment focus
  • SWOT
• 15.18 Ypsomed Holding AG
  • Ypsomed Holding AG - Overview
  • Ypsomed Holding AG - Business segments
  • Ypsomed Holding AG - Key offerings
  • Ypsomed Holding AG - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations